Positions

Selected Publications

Academic Article

Year Title Altmetric
2020 Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE) 2020
2020 Second-line treatment for metastatic pancreatic cancer 2020
2020 Patient-reported cognitive complaints in older adults with gastrointestinal malignancies at diagnosis– Results from the Cancer & Aging Resilience Evaluation (CARE) study 2020
2019 Association between primary perioperative CEA ratio, tumor site, and overall survival in patients with colorectal cancer 2019
2019 Disparities in clinical outcomes across age, sex and race among patients with pancreatic adenocarcinoma: a single center experience 2019
2019 Efficacy and tolerability of the combination of Liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic cancers: post-approval clinic experience 2019
2019 Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy for patients with locally advanced pancreatic cancer 2019
2019 Outcomes of Gastrointestinal cancers treated on Phase 1 clinical trials at O'Neal Comprehensive Cancer Center 2019
2019 Recent advances in the systemic treatment of gastrointestinal malignancy 2019
2019 Stereotactic body radiotherapy in locally advanced pancreatic adenocarcinoma: A single institution experience 2019
2019 Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors 2019
2019 Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging with a Point-of-Care Perfusion Phantom: A Pilot Study 2019
2019 Advances in pancreatic cancer biomarkers 2019
2019 Esophageal and esophagogastric junction cancers, Version 2.2019 2019
2019 Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials 2019
2018 Immune checkpoint inhibitors in the management of malignancies in transplant recipients 2018
2017 2017 ASCO Highlights on Gastointestinal Malignancies 2017
2017 Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer 2017
2016 Focused update on Gastrointestinal (GI) Oncology from ASCO 2016 2016
2016 Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin 2016
2016 Extramedullary Involvement by Chronic Myelogeneous Leukemia in Five Patients With Unusual Clinicopathologic Features: A Review of the Effectiveness of Tyrosine Kinase Inhibitors. 2016
2015 Unique presentation of blastic plasmacytoid dendritic cell neoplasm: A single-center experience and literature review 2015
2015 Effect of African-American Race on Tumor Recurrence after Radical Cystectomy for Urothelial Carcinoma of the Bladder 2015
2015 Capsule Commentary on Berkowitz et al., Building Equity Improvement into Quality Improvement: Reducing Socioeconomic Disparities in Colorectal Cancer Screening as Part of Population Health Management 2015
2014 Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experience 2014
2014 Update in systemic therapy of urologic malignancies 2014
2013 Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis of randomized clinical trials 2013

Principal Investigator On

  • Private Grant  awarded by MINNEAMRITA THERAPEUTICS, LLC 2018 - 2023
  • Private Grant  awarded by BOSTON BIOMEDICAL, INC. 2017 - 2022
  • Private Grant  awarded by MedImmune 2019 - 2022
  • Private Grant  awarded by HALOZYME, INC. 2016 - 2021
  • Private Grant  awarded by MOMENTA PHARMACEUTICALS, INC. 2016 - 2020
  • Private Grant  awarded by GLOBEIMMUNE, INC. 2016 - 2020
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2016 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2018 - 2019
  • Private Grant  awarded by BIOCARTIS US INC. 2018 - 2019
  • Private Grant  awarded by REXAHN PHARMACEUTICALS, INC. 2016 - 2018
  • Private Grant  awarded by NEWLINK GENETICS, INC 2016 - 2017
  • Investigator On

  • SWOG Purchase Services Agreement  awarded by Oregon Health & Science University 2020 - 2025
  • Private Grant  awarded by ARCUS BIOSCIENCES INC 2020 - 2025
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2020 - 2025
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2020 - 2025
  • Private Grant  awarded by ELI LILLY AND COMPANY 2019 - 2024
  • Private Grant  awarded by CALITHERA BIOSCIENCES INC 2019 - 2024
  • Private Grant  awarded by PUMA BIOTECHNOLOGY, INC. 2019 - 2024
  • Private Grant  awarded by CELGENE CORPORATION 2019 - 2024
  • Private Grant  awarded by Sanofi US Services Inc 2018 - 2023
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2023
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2019 - 2023
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2018 - 2023
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2019 - 2022
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2017 - 2022
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2019 - 2022
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2017 - 2022
  • Private Grant  awarded by INCYTE CORPORATION 2017 - 2022
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2021
  • Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2016 - 2021
  • UAB 1764:The Targeted Agent and Profiling Utilization Registry (TAPUR) Study  awarded by American Society of Clinical Oncology 2017 - 2020
  • Private Grant  awarded by MIRATI THERAPEUTICS, INC. 2015 - 2020
  • Alliance for Clinical Trials in Oncology Payment Agreement  awarded by MAYO CLINIC 2017 - 2020
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • Southwest Oncology Group Purchase Service Agreement  awarded by Oregon Health & Science University 2015 - 2020
  • Private Grant  awarded by AILERON THERAPEUTICS 2015 - 2020
  • Private Grant  awarded by ELI LILLY AND COMPANY 2015 - 2019
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2017 - 2019
  • Private Grant  awarded by INCYTE CORPORATION 2015 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2017 - 2019
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2019
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2019
  • Private Grant  awarded by ROCHE TCRC, INC. 2018 - 2019
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2019
  • Private Grant  awarded by ELI LILLY AND COMPANY 2016 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2017 - 2019
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • Private Grant  awarded by MERCK & COMPANY, INC. 2019
  • Private Grant  awarded by NAVIDEA BIOPHARMACEUTICALS, INC. 2017 - 2019
  • Private Grant  awarded by BIOCOMPATIBLES UK LTD 2016 - 2018
  • Private Grant  awarded by REXAHN PHARMACEUTICALS, INC. 2016 - 2017
  • Private Grant  awarded by HALOZYME, INC. 2016
  • Private Grant  awarded by MOMENTA PHARMACEUTICALS, INC. 2015 - 2016
  • Private Grant  awarded by AILERON THERAPEUTICS 2015
  • Education And Training

  • Bachelor of Medicine & Surgery (MBBS), Kakatiya University 2007
  • UAB Hospital, Residency 2012
  • UAB Hospital, Postdoctoral Fellowship 2015
  • Full Name

  • Ravi Paluri